Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial
about
Interventions for idiopathic intracranial hypertensionThe diagnosis and management of idiopathic intracranial hypertension and the associated headacheEvolving evidence in adult idiopathic intracranial hypertension: pathophysiology and managementIdiopathic intracranial hypertension: ongoing clinical challenges and future prospectsVisual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.The idiopathic intracranial hypertension treatment trial: clinical profile at baselineTherapeutic approaches to pediatric pseudotumor cerebri: New insights from literature data.Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial.High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failureBaseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variabilityIdiopathic intracranial hypertension in the Middle East: A growing concernApplications of optical coherence tomography in pediatric clinical neuroscience.Headache determines quality of life in idiopathic intracranial hypertension.Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results.Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.Risk factors for poor visual outcome in patients with idiopathic intracranial hypertensionRetinal and Choroidal Folds in Papilledema.Papilledema associated with puberty.Clarithromycin Culprit of Benign Intracranial HypertensionCauses and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension.Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension.Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension.Neuroimaging Features of Idiopathic Intracranial Hypertension Persist After Resolution of Papilloedema.Idiopathic intracranial hypertension presenting as postpartum headacheBariatric Surgery or Non-surgical Weight Loss for Idiopathic Intracranial Hypertension? A Systematic Review and Comparison of Meta-analyses.New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.Headache and the pseudotumor cerebri syndrome.The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension.Acetazolamide for the treatment of idiopathic intracranial hypertension.The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.Visual discrimination training improves Humphrey perimetry in chronic cortically induced blindness.The impact of ocular hemodynamics and intracranial pressure on intraocular pressure during acute gravitational changes.Idiopathic intracranial hypertension: Contemporary review and implications for the otolaryngologist.Decreased levels of aquaporin-4 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.Optic Nerve.Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment TrialIdiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management.A Possible Role for Temporary Lumbar Drainage in the Management of Idiopathic Intracranial Hypertension.
P2860
Q24187976-B6F27288-04DE-488E-8F70-AC638D04C523Q26745691-54F58A59-D8F2-4EF3-AED2-2CD598645EF2Q26765034-D463E150-EEFF-436F-8A5B-C9525BC48E9FQ26765260-7AA5F657-5B3C-4CEE-ACF3-75244DFAFA73Q30356839-41D09784-82A0-4966-BC4F-3A56280AE5E7Q30370124-12A5D564-8ADB-4452-A7AC-56E23BA61B99Q30393845-5C2BB947-C45B-4B2F-9F2C-904C7D1767D5Q31146225-15BEC138-52FF-4E39-956D-3B162883D715Q33658064-E2B7DD66-BB02-4472-A6AF-9963C06B79C3Q34091115-F343FB3D-2D56-4D27-BFCF-EE22EC638143Q34700012-BF04331E-1C33-4E34-BC71-EA9F62A64762Q35040672-E3EFC773-19CB-4FF8-B494-4246909C0CB8Q35620366-3FBB4EB9-9A8F-48EC-8FA4-DD02853C7919Q35620869-AD929341-6043-4796-B47A-2DF3101DF4C8Q35771980-A4C91B27-E5E6-47F6-B0FB-C7CB357ABD86Q35995529-C7960238-1339-4EF4-9865-4303E4AFED9AQ36005622-CF469C06-D429-45C3-9120-F2B186915D35Q36035678-D5FFE66F-F96D-41B5-AF11-0AD99851BA2FQ36277112-7BEC35DA-DC31-4192-93C4-27BA3BFDD13CQ36383816-009BC56A-CF36-46CF-9E12-CEBBEDD98480Q36420646-B6010BA0-10F0-402D-A80F-DBFC64220307Q37244512-0738EA02-1DFB-49C5-9A42-9C30C2D6A61CQ37439414-9A4A4E97-A66E-49F7-846A-75CA2680CCD2Q37439881-441715C2-3414-419F-AA97-5E6D633B3589Q37577298-87007684-17F0-49B1-9996-5B24D8820BA5Q37587255-1F420015-18DA-45A8-880B-F7BAF5C92106Q38235629-387DCDE0-61DA-4981-BBB4-1684E29AC790Q38236305-C9B1C33B-BF5B-4A90-8E8C-58FE41FF5E20Q38285279-22650E4B-5293-42E7-A90A-D6116B22290CQ38543994-58CA1991-5038-4696-B51C-0E4F686DD823Q38652472-95D92BCC-BEFD-4A94-A4B5-C010E9349E54Q38731001-EE28BC4C-FB9C-485D-8B33-F451234F7128Q38790994-63A6BE65-BB31-4124-B7F0-74AC5CE53780Q38871789-7DC527A9-7E57-489C-B778-9583C4E0AF67Q40016259-3D280C73-F843-4A08-AD4B-887884C0AA90Q40400522-AC7069F2-9F23-4B10-B3DA-C06E506FF344Q40481942-49F5BCB9-5C8C-404A-ACF2-7AB94B26A36FQ40501675-3495AB0D-4C8F-48A3-9799-21512BE0C4B7Q41528844-6328A5C5-65D8-426D-B4EF-C3B782252960Q41697808-328B670C-1E09-4AC3-815C-C00CE6575A81
P2860
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of acetazolamide on vis ...... l hypertension treatment trial
@ast
Effect of acetazolamide on vis ...... l hypertension treatment trial
@en
type
label
Effect of acetazolamide on vis ...... l hypertension treatment trial
@ast
Effect of acetazolamide on vis ...... l hypertension treatment trial
@en
prefLabel
Effect of acetazolamide on vis ...... l hypertension treatment trial
@ast
Effect of acetazolamide on vis ...... l hypertension treatment trial
@en
P2093
P2860
P356
P1476
Effect of acetazolamide on vis ...... l hypertension treatment trial
@en
P2093
David M Katz
Deborah I Friedman
Eleanor B Schron
James J Corbett
John L Keltner
Karl D Kieburtz
Mark J Kupersmith
Michael P McDermott
Michael Wall
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee
P2860
P304
P356
10.1001/JAMA.2014.3312
P407
P577
2014-04-01T00:00:00Z